Key result
Aspirin utilization for preeclampsia prevention in high- and moderate-risk pregnancies remains poorly documented in clinical practice despite professional society recommendations.
Why the study?
Aspirin is recommended for preeclampsia prevention in high- and moderate-risk pregnancies, but little is published regarding its utilization in clinical practice.
Indicates persistent gaps in guideline implementation; leaves open the need for studies on barriers and strategies to improve aspirin uptake.
Aspirin (ASA) for preeclampsia prevention in high and moderate risk pregnancies is recommended by professional societies, but little is published about utilization in clinical practice. We aimed to describe ASA utilization in pregnancies meeting the 2014 US Preventative Services Task Force criteria and by risk factors (RF).
No takes yet. Share an insight, caveat, or question.
Tesfalul et al. (2021) studied this question. Aspirin utilization for preeclampsia prevention in high- and moderate-risk pregnancies remains poorly documented in clinical practice despite professional society recommendations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: